Central sensitisation phenomena in primary headaches: Overview of a preventive therapeutic approach

CNS and Neurological Disorders - Drug Targets

Volumn 7, Issue 6, 2008, Pages 524-535

  de Tommaso, M ^a   Sardaro, M ^a   Vecchio, E ^a   Serpino, C ^a   Stasi, M ^a   Ranieri, M ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Central sensitisation; Headache; Preventive therapies

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CITALOPRAM; DOPAMINE; DULOXETINE; FLUNARIZINE; GABAPENTIN; GLUTAMIC ACID; LAMOTRIGINE; PAROXETINE; PLACEBO; SEROTONIN RECEPTOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; VERAPAMIL;

ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; CHRONIC TENSION HEADACHE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROMYOGRAPHY; EXERCISE; FIBROMYALGIA; HEADACHE; HUMAN; JOINT MOBILITY; LEISURE; MIGRAINE; MUSCLE STRENGTH; MYOTATIC REFLEX; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIMARY HEADACHE; QUALITY OF LIFE; REVIEW; SELF CARE; SENSITIZATION; TENSION HEADACHE; TRANSFORMED MIGRAINE;

ANIMALS; FIBROMYALGIA; HEADACHE; HUMANS; MIGRAINE DISORDERS; PAIN; SLEEP DEPRIVATION; THIOPHENES;

EID: 70350017849     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152708787122932     Document Type: Review

References (72)

1. Tracey, I.; Mantyh, P.W. The cerebral signature for pain perception and its modulation. Neuron, 2007, 55, 377-391.
2. Fields, H.L. Special Lecture. Pain modulating networks in headache pathogenesis. Cephalalgia, 2001, 21, 273.
3. Lipton, R.B.; Stewart, W.F.; Diamond, S.; Diamond, M.L.; Reed, M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache, 2001, 41, 646-57.
4. Headache Classification Committee. Cephalalgia, 2004, 24, 24-136.
5. Schwartz, B.S.; Stewart, W.F.; Simon, D.; Lipton, R.B. Epidemiology of tension-type headache. JAMA, 1998, 279, 381-3.
6. Burstein, R.; Cutrer, M.F.; Yarnitsky, D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain, 2000, 123, 1703-9.
7. Bendtsen, L. Central sensitization in tension-type headache - possible pathophysiological mechanisms. Cephalalgia, 2000, 20, 486-508.
8. Buchgreitz, L.; Lyngberg, A.C.; Bendtsen, L.; Jensen, R. Frequency of headache is related to sensitization: a population study. Pain, 2006, 123, 19-27.
9. de Tommaso, M.; Sardaro, M.; Serpino, C.; Vecchio, E.; Prudenzano, M.P.; Lamberti, P.; Livrea, P. Fibromyalgia comorbidity in primary headaches. Cephalalgia, 2008, in press.
10. Goadsby, P. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol. Med., 2006, 13, 39-44.
11. Fumal, A.; Schoenen J. Tension-type headache: current research and clinical management. Lancet Neurol., 2008, 7, 70-83.
12. Lovati, C.; D'Amico, D.; Bertora, P.; Rosa, S.; Suardelli, M.; Mailland, E.; Mariani, C.; Bussone, G. Acute and Interictal Allodynia in Patients With Different Headache Forms: An Italian Pilot Study. Headache, 2008, 48, 272-277.
13. Beghi, E.; Allais, G.; Cortelli, P.; D'Amico, D.; De Simone, R.; d'Onofrio, F.; Genco, S.; Manzoni, G.C.; Moschiano, F.; Tonini, M.C.; Torelli, P.; Quartaroli, M.; Roncolato, M.; Salvi, S.; Bussone, M. Headache and anxiety-depressive disorder comorbidity: the HADAS study. J. Neurol. Sci., 2007, 28, S217-9.
14. Juang, K.D.; Wang, S.J.; Fuh, J.L.; Lu, S.R.; Su, T.P. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache, 2000, 40, 818-23.
15. Tietjen, G.E.; Brandes, J.L.; Digre, K.B. Baggaley, S.; Martin, V.; Recober, A.; Geweke, L.O.; Hafeez, F.; Aurora, S.K.; Herial, N.A.; Utley, C.; Khuder, S.A. High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology, 2007, 68, 134-40.
16. Wang, S.J.; Juang, K.D.; Fuh, J.L.; Lu, S.R. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology, 2007, 68, 1468-73.
17. Rains, J.C.; Poceta, J.S. Headache and sleep disorders: review and clinical implications for headache management. Headache, 2006, 46, 1344-63.
18. Lautenbacher, S.; Kundermann, B.; Krieg, J.C. Sleep deprivation and pain perception. Med. Rev., 2006, 10, 357-69.
19. Vikelis, M.; Mitsikostas, D.D. The increased glutamate transmission through interaction with its ionotropic and metabotropic receptors, seems to subtend peripheral and central sensitisation in both chronic migraine and fibromyalgia. CNS Neurol. Disord. Drug Targets, 2007, 6, 251-257.
20. Sarchielli, P.; Di Filippo, M.; Nardi, K.; Calabresi, P. Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr. Pain Headache Rep., 2007, 11, 343-51.
21. Zeilhofer, H.U. Loss of glycinergic and GABAergic inhibition in chronic pain-contributions of inflammation and microglia. Int. Immunopharmacol., 2008, 8, 182-187.
22. Abeles, M.; Solitar, B.M.; Pillinger, M.H.; Abeles, A. Update on fibromyalgia therapy. Am. J. Med., 2008, 121, 555-61.
23. Fields, H. State-dependent opioid control of pain. Nat. Rev. Neurosci., 2004, 5, 565-575.
24. Maizels, M.; MacCarberg, B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am. Fam. Physician., 2005, 71, 483-490.
25. Matsuzawa-Yanagida, K.; Narita, M.; Nakajima, M.; Kuzumaki, N.; Niikura, K.; Nozaki, H.; Takagi, T.; Tamai, E.; Hareyama, N.; Terada, M.; Yamazaki, M.; Suzuki, T. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacol., 2008, 33, 1952-65.
26. Scheggi, S.; Leggio, B.; Masi, F.; Grappi, S.; Gambarana, C.; Nanni, G.; Rauggi, R.; De Montis, M.G. Selective modifications in the nucleus accumbens of dopamine synaptic transmission in rats exposed to chronic stress. J. Neurochem., 2002, 83, 895-903.
27. Wood, P.B.; Patterson, J.C.; Sunderland, J.J.; Tainter, K.H.; Glabus, M.F.; Lilien, D.L. APET activation study of brush-evoked allodynia in patients with nerve injury pain. J. Pain, 2007, 8, 51-58.
28. Wood, P.B. Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med. Hypotheses, 2004, 62, 420-424.
29. Akerman, S.; Goadbsy, P.J. Topiramate inhibits cortical spreading depression in rat and cat: Impact in migraine aura. Cephalalgia, 2007, 11, 1308-1314.
30. Lipton, R.B.; Bigal, M.E.; Diamond, F.; Freitag, M.L.; Stewart, W.F. Migraine prevalence, disease burden, and the need for preventive therapy, AMPP Advisory Group. Neurology, 2007, 30, 343-349.
31. Silberstein, S.D. Preventive treatment of migraine. Trends Pharmacol. Sci., 2006, 27, 410-415.
32. Burstein, R.; Collins, B.; Jakubowski, M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann. Neurol., 2004, 55, 19-26.
33. de Tommaso, M.; Losito, L.; Libro, G.; Guido, M.; Lamberti, P.; Livrea, P. Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack. Cephalalgia, 2005, 25, 359-368.
34. Johannessen, L.C. Antiepileptic Drugs in Non-Epilepsy Disorders: Relations between Mechanisms of Action and Clinical Efficacy. CNS Drugs, 2008, 22, 27-47.
35. de Tommaso, M.; Marinazzo, D.; Nitti, L.; Pellicoro, M.; Guido, M.; Serpino, C.; Stramaglia, S. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. Clin. Neurophysiol., 2007, 118, 2297-2304.
36. de Tommaso, M.; Guido, M.; Sardaro, M.; Serpino, C.; Vecchio, E.; De Stefano, G.; Di Claudio, T.; Specchio, L.M.; Livrea, P. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neurosci. Lett., 2008, 442, 81-85.
37. Silberstein, S.D. Topiramate in migraine prevention. Headache, 2005, 45, S57-S65
38. Brandes, J.L.; Saper, J.R.; Diamond, M.; Couch, J.R.; Lewis, D.W.; Schmitt, J.; Neto, W.; Schwabe, S.; Jacobs, D. MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA, 2004, 291, 965-973.
39. Diener, H.C.; Tfelt-Hansen, P.; Dahlof, C.; Lainez, M.J.; Sandrini, G.; Wang, S.J.; Neto, W.; Vijapurkar, U.; Doyle, A.; Jacobs, D. Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J. Neurol., 2004, 251, 943-950.
40. MacDonald, R.L.; McLean, M.J. Anticonvulsant drugs: mechanisms of action. In Advances in Neurology, Escueta, A.D. et al., Eds.; Raven Press: 1986; pp. 713-36.
41. Dodgson, S.J.; Shank, R.P.; Maryanoff, B.E. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia, 2000, 41, S35-S39.
42. Akerman, S.; Goadsby, P.J. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport, 2005, 16, 1383-7.
43. Storer, R.J.; Goadsby, P.J. Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia, 2004, 24, 1049-56.
44. Yung, C.O.; Bruehl, S.P. Complex Regional Pain Syndrome. Curr. Treat Options Neurol., 2003, 5, 499-511.
45. Codd, E.E.; Martinez, R.P.; Molino, L.; Rogers, K.E.; Stone, D.J.; Tallarida, R.J.; Pol, J. Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia. Pain, 2008, 134, 254-62.
46. Wieczorkiewicz-Płaza, A.; Płaza, P.; Maciejewski, R.; Czuczwar, M.; Przesmycki, K. Effect of topiramate on mechanical allodynia in neuropathic pain model in rats. Pol. J. Pharmacol., 2004, 56, 275-8.
47. Ettinger, A.B.; Argoff, C.E. Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain. Neurotherapeutics, 2007, 4, 75-83.
48. Gray, R.N.; Goslin, R.E.; McCrory, D.C.; Penzien, D.; Rains, J.; Hasselblad, V. National Technical Information, 1999, Service Accession no. 127953.
49. Freitag, F.G.; Collins, S.D.; Carlson, H.A.; Goldstein, J.; Saper, J.; Silberstein, S.; Mathew, N.; Winner, P.K.; Deaton, R.; Sommerville, K.; Depakote ER Migraine Study Group. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology, 2002, 58, 1652-1659.
50. Zin, C.S.; Nissen, L.M.; Smith, M.T.; O'Callaghan, J.P.; Moore, B.J. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs, 2008, 22, 417-42.
51. Ramadan, N.M.; Buchanan, T.M. New and future migraine therapy. Pharmacol. Therapeut., 2006, 112, 199-212.
52. Silberstein, S.D.; Goadsby, P.J. Migraine: preventive treatment. Cephalalgia, 2002, 22, 491-51.
53. Ramadan, N.M. Current trends in migraine prophylaxis. Headache, 2007, 47, S52-S57.
54. Keskinbora, K.; Aydinli, I. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Clin. Neurol. Neurosurg., 2008, 110, 979-84.
55. Rampello, L.; Alvano, A.; Chiechio, S.; Malaguarnera, M.; Raffaele, R.; Vecchio, I.; Nicolett, I.F. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology, 2004, 50, 322-28.
56. Taylor, A.P.; Adelman, J.U.; Freeman, M.C. Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review. Headache, 2007, 47, 1200-3.
57. Perrot, S. Medication to treat fibromyalgia? Rev. Med. Suisse, 2007, 20, 1575-8.
58. Omote, K.; Iwasaki, H.; Kawamata, M.; Satoh, O.; Namiki. A. Effects of verapamil on spinal anesthesia with local anesthetics. Anesth. Analg., 1995, 80, 444-448.
59. Knight, Y.E.; Bartsch, T.; Kaube, H.; Goadsby, P.J. P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J. Neurosci., 2002, 22, RC213.
60. Patten, S.; Thompson, J. Organic depression associated with flunarizine. Can. J. Psychiary, 1995, 40, 111-2.
61. Bendtsen, L.; Jensen, R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia, 2000, 20, 603-610.
62. de Tommaso, M.; Shevel, E.; Pecoraro, C.; Sardaro, M.; Divenere, D.; Difruscolo, O.; Lamberti, P.; Livrea, P. Intra-oral orthosis vs amitriptyline in chronic tension-type headache: a clinical and laser evoked potentials study. Head Face Med., 2006, 25, 15.
63. Henningsen, P.; Zipfel, S.; Herzog, W. Management of functional somatic syndromes. Lancet, 2007, 369, 946-55.
64. Turk, D.C.; Swanson, K.S.; Tunks, E.R. Psychological approaches in the treatment of chronic pain patients-when pills, scalpels, and needles are not enough. Can. J. Psychiatry, 2008, 53, 213-23.
65. Smitherman, T.A.; Penzien, D.B.; Rains, J.C. Challenges of nonpharmacologic interventions in chronic tension-type headache. Curr. Pain Headache, 2007, 11, 471-77
66. Abeles, A.M.; Pillinger, M.H.; Solitar, B.M.; Abeles, M. Narrative review: the pathophysiology of fibromyalgia. Ann. Int. Med., 2007, 15, 726-34.
67. Wolfe, F.; Smythe, H.A.; Yunus, M.B.; Bennet, R.M.; Bombardier, C.; Goldenberg, D.L.; Tugwell, P.; Campbell, S.M.; Abeles, M.; Clark, P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum., 1990, 33, 160-72.
68. Langermark, M.; Olesen, J. Pericranial tenderness in tension headache. A blind, controlled study. Cephalalgia, 1987, 7, 249-55.
69. Zung, W.W.K. A self-rating depression scale, Arch. Gen. Psychiatry, 1965, 12, 63-70.
70. Zung, W.W.K. ECDEU Assessment Manual for Psychopharmacology, revised ed.; Guy, W. Ed.; Rockville, 1976, pp. 337-340.
71. Hays, R.D.; Stewart, A.L. Sleep measures. In Measuring functioning and well-being; Stewart, A.L.; Ware, J.E. Jr., Eds.; Duke University Press: Durham, 1992, 235-9.
72. Ware, J.E.; Kosinski, M.; Dewey, J.E. How to score version 2 of the SF-36 (r) health survey. Lincoln RI: Quality Metric Incorporated, 2000.